Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy.
Ciravolo V, Huber V, Ghedini GC, Venturelli E, Bianchi F, Campiglio M, Morelli D, Villa A, Della Mina P, Menard S, Filipazzi P, Rivoltini L, Tagliabue E, Pupa SM.
Ciravolo V, et al. Among authors: huber v.
J Cell Physiol. 2012 Feb;227(2):658-67. doi: 10.1002/jcp.22773.
J Cell Physiol. 2012.
PMID: 21465472